Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI Singapore) at the National University of...
Singapore: Certara, a drug development and drug safety consultancy firm has launched its D360 software in Japan for prov...
Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA for the develop...
Singapore: Australia-based clinical-stage drug development company, Invion, initiated and commenced patient enrolment in...
Singapore: Breast cancer therapeutics pipeline has higher innovation in first-in-class molecules, with many new technolo...
Singapore: Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, plans to begin a Phase 2 clinical trial o...
Singapore: Singapore's biopharmaceutical company, MerLion Pharmaceuticals, has recieved positive results from a phase 2 ...
Singapore: Ally Bridge Group (ABG), a global healthcare-focused investment platform, has expanded its global biopharmace...
Singapore: Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by s...
Singapore: A small freshwater fish found in many tropical aquariums may hold the key to unlocking one of the leading cau...
Singapore: Otsuka Pharmaceutical received a Complete Response Letter (CRL) from the US FDA regarding the new drug applic...
Singapore: Allied-Bristol Life Sciences, a jointly owned enterprise between Allied Minds and Bristol-Myers Squibb, has a...
Singapore: US based biotech firm, Genocea Biosciences, has identified a cluster of antigens, generated using its ATLAS a...
Singapore: National University of Singapore has demonstrated effectiveness of artesunate, a common herbal-based anti-mal...
Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has f...
Singapore: Japan-based Dainippon Sumitomo Pharma (DSP), has decided to establish an anti-cancer drugs sales company in t...
Singapore: Japanese company, Kyowa Hakko Kirin and Korean firm, Syndax Pharmaceuticals, have entered into a license agre...
Singapore: Cantrixil, a first-in-class experimental chemotherapeutic, developed by Australia/US-based biotech firm Novog...
